What is a Challenging Clot? : A DELPHI Consensus Statement from the CLOTS 7.0 Summit.


Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 27 03 2023
accepted: 27 04 2023
medline: 20 11 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

Predicting a challenging clot when performing mechanical thrombectomy in acute stroke can be difficult. One reason for this difficulty is a lack of agreement on how to precisely define these clots. We explored the opinions of stroke thrombectomy and clot research experts regarding challenging clots, defined as difficult to recanalize clots by endovascular approaches, and clot/patient features that may be indicative of such clots. A modified DELPHI technique was used before and during the CLOTS 7.0 Summit, which included experts in thrombectomy and clot research from different specialties. The first round included open-ended questions and the second and final rounds each consisted of 30 closed-ended questions, 29 on various clinical and clot features, and 1 on number of passes before switching techniques. Consensus was defined as agreement ≥ 50%. Features with consensus and rated ≥ 3 out of 4 on the certainty scale were included in the definition of a challenging clot. Three DELPHI rounds were performed. Panelists achieved consensus on 16/30 questions, of which 8 were rated 3 or 4 on the certainty scale, namely white-colored clots (mean certainty score 3.1), calcified clots under histology (3.7) and imaging (3.7), stiff clots (3.0), sticky/adherent clots (3.1), hard clots (3.1), difficult to pass clots (3.1) and clots that are resistant to pulling (3.0). Most panelists considered switching endovascular treatment (EVT) techniques after 2-3 unsuccessful attempts. This DELPHI consensus identified 8 distinct features of a challenging clot. The varying degree of certainty amongst the panelists emphasizes the need for more pragmatic studies to enable accurate a priori identification of such occlusions prior to EVT.

Sections du résumé

BACKGROUND BACKGROUND
Predicting a challenging clot when performing mechanical thrombectomy in acute stroke can be difficult. One reason for this difficulty is a lack of agreement on how to precisely define these clots. We explored the opinions of stroke thrombectomy and clot research experts regarding challenging clots, defined as difficult to recanalize clots by endovascular approaches, and clot/patient features that may be indicative of such clots.
METHODS METHODS
A modified DELPHI technique was used before and during the CLOTS 7.0 Summit, which included experts in thrombectomy and clot research from different specialties. The first round included open-ended questions and the second and final rounds each consisted of 30 closed-ended questions, 29 on various clinical and clot features, and 1 on number of passes before switching techniques. Consensus was defined as agreement ≥ 50%. Features with consensus and rated ≥ 3 out of 4 on the certainty scale were included in the definition of a challenging clot.
RESULTS RESULTS
Three DELPHI rounds were performed. Panelists achieved consensus on 16/30 questions, of which 8 were rated 3 or 4 on the certainty scale, namely white-colored clots (mean certainty score 3.1), calcified clots under histology (3.7) and imaging (3.7), stiff clots (3.0), sticky/adherent clots (3.1), hard clots (3.1), difficult to pass clots (3.1) and clots that are resistant to pulling (3.0). Most panelists considered switching endovascular treatment (EVT) techniques after 2-3 unsuccessful attempts.
CONCLUSION CONCLUSIONS
This DELPHI consensus identified 8 distinct features of a challenging clot. The varying degree of certainty amongst the panelists emphasizes the need for more pragmatic studies to enable accurate a priori identification of such occlusions prior to EVT.

Identifiants

pubmed: 37284876
doi: 10.1007/s00062-023-01301-2
pii: 10.1007/s00062-023-01301-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1007-1016

Subventions

Organisme : Cerenovus
ID : not applicable (Cerenovus funded the transportation and accomodation for the CLOTS 7.0 panelists)

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723–31. https://doi.org/10.1016/S0140-6736(16)00163-X .
doi: 10.1016/S0140-6736(16)00163-X pubmed: 26898852
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708–18. https://doi.org/10.1056/NEJMoa1713973 .
doi: 10.1056/NEJMoa1713973 pubmed: 29364767 pmcid: 6590673
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21. https://doi.org/10.1056/NEJMoa1706442 .
doi: 10.1056/NEJMoa1706442 pubmed: 29129157
Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large Ischemic region. N Engl J Med. 2022;386:1303–13. https://doi.org/10.1056/NEJMoa2118191 .
doi: 10.1056/NEJMoa2118191 pubmed: 35138767
Brouwer PA, Brinjikji W, De Meyer SF. Clot pathophysiology: why is it clinically important? Neuroimaging Clin N Am. 2018;28(20180915):611–23. https://doi.org/10.1016/j.nic.2018.06.005 .
doi: 10.1016/j.nic.2018.06.005 pubmed: 30322597 pmcid: 6910231
Fitzgerald S, Mereuta OM, Doyle KM, et al. Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome. J Neurosurg Sci. 2019;63(20181205):292–300. https://doi.org/10.23736/S0390-5616.18.04629-5 .
doi: 10.23736/S0390-5616.18.04629-5 pubmed: 30514073
Staessens S, Fitzgerald S, Andersson T, et al. Histological stroke clot analysis after thrombectomy: technical aspects and recommendations. Int J Stroke. 2020;15:467–76. https://doi.org/10.1177/1747493019884527 .
doi: 10.1177/1747493019884527 pubmed: 31679478
De Meyer SF, Andersson T, Baxter B, et al. Analyses of thrombi in acute ischemic stroke: a consensus statement on current knowledge and future directions. Int J Stroke. 2017;12:606–14. https://doi.org/10.1177/1747493017709671 .
doi: 10.1177/1747493017709671 pubmed: 28534706
Benson JC, Kallmes DF, Larson AS, et al. Radiology-pathology correlations of Intracranial clots: current theories, clinical applications, and future directions. AJNR Am J Neuroradiol. 2021;42:1558–65. https://doi.org/10.3174/ajnr.A7249 .
doi: 10.3174/ajnr.A7249 pubmed: 34301640 pmcid: 8423051
D C. How to train your oracle: the Delphi method and its turbulent youth in operations research and the policy sciences. Soc Stud Sci. 2018; https://doi.org/10.1177/0306312718798497 .
doi: 10.1177/0306312718798497
Steurer J. The Delphi method: an efficient procedure to generate knowledge. Skelet Radiol. 2011;40:959–61. https://doi.org/10.1007/s00256-011-1145-z .
doi: 10.1007/s00256-011-1145-z
Dalkey NC, H O. An experimental application of the Delphi Method to the Use of Experts. Santa Monica, CA. 1962.
Goyal M, Orlov K, Jensen ME, et al. A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy. Neuroradiology. 2021;63:627–32. https://doi.org/10.1007/s00234-020-02556-z .
doi: 10.1007/s00234-020-02556-z pubmed: 32974691
Goyal M, Yoshimura S, Milot G, et al. Considerations for antiplatelet management of carotid stenting in the setting of mechanical thrombectomy: a Delphi consensus statement. AJNR Am J Neuroradiol. 2020;41:2274–9. https://doi.org/10.3174/ajnr.A6888 .
doi: 10.3174/ajnr.A6888 pubmed: 33122218 pmcid: 7963237
Ospel JM, Brouwer P, Dorn F, et al. Antiplatelet management for stent-assisted coiling and flow diversion of ruptured Intracranial aneurysms: a DELPHI consensus statement. AJNR Am J Neuroradiol. 2020;41:1856–62. https://doi.org/10.3174/ajnr.A6814 .
doi: 10.3174/ajnr.A6814 pubmed: 32943417 pmcid: 7661082
Maurer CJ, Dobrocky T, Joachimski F, et al. Endovascular thrombectomy of calcified emboli in acute Ischemic stroke: a multicenter study. AJNR Am J Neuroradiol. 2020;41:464–8. https://doi.org/10.3174/ajnr.A6412 .
doi: 10.3174/ajnr.A6412 pubmed: 32029470 pmcid: 7077917
Dobrocky T, Piechowiak E, Cianfoni A, et al. Thrombectomy of calcified emboli in stroke. Does histology of thrombi influence the effectiveness of thrombectomy? J Neurointerv Surg. 2018;10:345–50. https://doi.org/10.1136/neurintsurg-2017-013226 .
doi: 10.1136/neurintsurg-2017-013226 pubmed: 28798266
Grand T, Dargazanli C, Papagiannaki C, et al. Benefit of mechanical thrombectomy in acute ischemic stroke related to calcified cerebral embolus. J Neuroradiol. 2022;49:317–23. https://doi.org/10.1016/j.neurad.2022.02.006 .
doi: 10.1016/j.neurad.2022.02.006 pubmed: 35183595
Jolugbo P, Ariens RAS. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke. Stroke. 2021;52:1131–42. https://doi.org/10.1161/STROKEAHA.120.032810 .
doi: 10.1161/STROKEAHA.120.032810 pubmed: 33563020 pmcid: 7610448
Soize S, Pierot L, Mirza M, et al. Fast stent retrieval improves recanalization rates of thrombectomy: experimental study on different thrombi. AJNR Am J Neuroradiol. 2020;41:1049–53. https://doi.org/10.3174/ajnr.A6559 .
doi: 10.3174/ajnr.A6559 pubmed: 32409312 pmcid: 7342735
Wong GJ, Yoo B, Liebeskind D, et al. Frequency, determinants, and outcomes of emboli to distal and new territories related to mechanical thrombectomy for acute Ischemic stroke. Stroke. 2021;52:2241–9. https://doi.org/10.1161/STROKEAHA.120.033377 .
doi: 10.1161/STROKEAHA.120.033377 pubmed: 34011171
Fereidoonnezhad B, Dwivedi A, Johnson S, et al. Blood clot fracture properties are dependent on red blood cell and fibrin content. Acta Biomater. 2021;127:213–28. https://doi.org/10.1016/j.actbio.2021.03.052 .
doi: 10.1016/j.actbio.2021.03.052 pubmed: 33812070
Brinjikji W, Nogueira RG, Kvamme P, et al. Association between clot composition and stroke origin in mechanical thrombectomy patients: analysis of the Stroke Thromboembolism Registry of Imaging and Pathology. J NeuroIntervent Surg. 2021;13:594. https://doi.org/10.1136/neurintsurg-2020-017167 .
doi: 10.1136/neurintsurg-2020-017167
Prochazka V, Jonszta T, Czerny D, et al. The role of von Willebrand factor, ADAMTS13, and cerebral artery thrombus composition in patient outcome following mechanical thrombectomy for acute ischemic stroke. Med Sci Monit. 2018;24:3929–45. https://doi.org/10.12659/MSM.908441 .
doi: 10.12659/MSM.908441 pubmed: 29887594 pmcid: 6029516
Sengeze N, Giray S. The relationship between first pass recanalization of stent-retriever-based thrombectomy and neutrophil to lymphocyte ratio in middle cerebral artery occlusions. Int J Neurosci. 2021;131:634–40. https://doi.org/10.1080/00207454.2020.1838513 .
doi: 10.1080/00207454.2020.1838513 pubmed: 33066715
Froehler MT, Tateshima S, Duckwiler G, et al. The hyperdense vessel sign on CT predicts successful recanalization with the Merci device in acute ischemic stroke. J Neurointerv Surg. 2013;5:289–93. https://doi.org/10.1136/neurintsurg-2012-010313 .
doi: 10.1136/neurintsurg-2012-010313 pubmed: 22619467
Kim SK, Baek BH, Lee YY, et al. Clinical implications of CT hyperdense artery sign in patients with acute middle cerebral artery occlusion in the era of modern mechanical thrombectomy. J Neurol. 2017;264:2450–6. https://doi.org/10.1007/s00415-017-8655-0 .
doi: 10.1007/s00415-017-8655-0 pubmed: 29075836
Mojtahedi M, Kappelhof M, Ponomareva E, et al. Fully automated thrombus segmentation on CT images of patients with acute ischemic stroke. Diagnostics (basel). 2022; https://doi.org/10.3390/diagnostics12030698 .
doi: 10.3390/diagnostics12030698 pubmed: 35328251
Santos EM, Niessen WJ, Yoo AJ, et al. Automated entire thrombus density measurements for robust and comprehensive thrombus characterization in patients with acute ischemic stroke. PLoS ONE. 2016;11:e145641. https://doi.org/10.1371/journal.pone.0145641 .
doi: 10.1371/journal.pone.0145641 pubmed: 26765847 pmcid: 4713144
Khismatullin RR, Nagaswami C, Shakirova AZ, et al. Quantitative morphology of cerebral thrombi related to Intravital contraction and clinical features of ischemic stroke. Stroke. 2020;51:3640–50. https://doi.org/10.1161/STROKEAHA.120.031559 .
doi: 10.1161/STROKEAHA.120.031559 pubmed: 33040705

Auteurs

Johanna M Ospel (JM)

Departments of Diagnostic Imaging and Clinical Neurosciences, Foothills Medical Centre, University of Calgary, 1403 29th St. NW, T2N2T9, Calgary, AB, Canada. johannaospel@gmail.com.

Mahmood Mirza (M)

Cerenovus, Galway, Ireland.

Frédéric Clarençon (F)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.

Adnan Siddiqui (A)

Department of Neurosurgery, University of New York at Buffalo, Buffalo, NY, USA.

Karen Doyle (K)

Department of Physiology and CURAM-SFI Research Centre for Medical Devices, University of Galway, Galway, Ireland.

Arturo Consoli (A)

Service de Neuroradiologie Diagnostique et Thérapeutique, Hôpital Foch, Suresnes, France.

Maxim Mokin (M)

Department of Neurosurgery and Brain Repair, University of South Florida, Tampa, FL, USA.

Teresa Ullberg (T)

Departments of Neurology and Diagnostic Imaging, Skåne University Hospital, and Department of clinical sciences, Neurology, Lund University, Lund, Sweden.

Osama Zaidat (O)

Neuroscience and Stroke Center, Mercy Health Bon Secours St Vincent Hospital, Toledo, OH, USA.

Romain Bourcier (R)

Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, L'institut du thorax, Nantes, Pays de la Loire, France.

Zsolt Kulcsar (Z)

Department of Neuroradiology, University Hospital of Zurich, Zurich, Switzerland.

Matthew J Gounis (MJ)

New England Center for Stroke Research, Department of Radiology, University of Massachusetts Chan Medical School, Worcester, USA.

David S Liebeskind (DS)

UCLA Stroke Center and Department of Neurology, University of California, Los Angeles, USA.

Jens Fiehler (J)

Department of Neuroradiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Ana Paula Narata (AP)

Department of Interventional Neuroradiology, University Hospital of Southampton, Southampton, UK.

Marc Ribo (M)

Unitat d'Ictus, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Tudor Jovin (T)

Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA.

Nobuyuki Sakai (N)

Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan.

Ansaar Rai (A)

Neuroradiology Department, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, USA.

Ray McCarthy (R)

Research and Development, Cerenovus, Galway, Ireland.

Franziska Dorn (F)

Department of Neuroradiology, University Hospital of Bonn, Bonn, Germany.

Tommy Andersson (T)

Department of Neuroradiology, Karolinska University Hospital and Clinical Neuroscience, Karolinska Intitutet, Stockholm, Sweden.

Charles B L M Majoie (CBLM)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, The Netherlands.

Ricardo Hanel (R)

Baptist neurological institute, Baptist Health, Jacksonville, FL, USA.

Ashutosh Jadhav (A)

Department of Neurosurgery, Barrow Neurological Institute, Phoenix, AZ, USA.

Christian Riedel (C)

Department of Neuroradiology, University Hospital Göttingen, Georg-August-University, Göttingen, Germany.

Angel Chamorro (A)

Hospital Clinic of Barcelona and Institut d'Investigaçions Biomèdicas August Pi Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.

Waleed Brinjikji (W)

Department of Radiology and Neurosurgery, Mayo Clinic Rochester, Rochester, MN, USA.

Vincent Costalat (V)

Neuroradiology department, University Hospital Güi-de-Chauliac, CHU de Montpellier, Montpellier, France.

Simon F DeMeyer (SF)

Laboratory For Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.

Raul G Nogueira (RG)

Department of Neurology, University of Pittsburgh Medical Centre, Pittsburgh, USA.

Christophe Cognard (C)

Department of diagnostic and therapeutic Neuroradiology, University Hospital of Toulouse, Toulouse, France.

Joan Montaner (J)

Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR) Barcelona, Barcelona, Spain.

Thomas W Leung (TW)

Department of Medicine and Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

Carlos Molina (C)

Stroke Center Vall d'Hebron Hospital, Barcelona, Spain.

Heleen van Beusekom (H)

Department of Cardiology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

Antoni Davalos (A)

Department of Neuroscience, University Autònoma de Barcelona, Barcelona, Spain.

John Weisel (J)

Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

Rene Chapot (R)

Department of Neuroradiology, Alfried Krupp Krankenhaus Ruttenscheid, Essen, Germany.

Markus Möhlenbruch (M)

Department of Interventional Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

Patrick Brouwer (P)

Head World Wide Medical Affairs, Cerenovus, Galway, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH